secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001213900-26-049748
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Ronald McClurg to retire June 30, 2026; COO Christopher Volker to succeed as CFO
--------------------------------------------------------------------------------

- Ronald McClurg to retire as CFO effective June 30, 2026, then serve as Senior Advisor until Dec 31, 2026.
- Christopher Volker, current COO, appointed CFO effective July 1, 2026; base salary increased to $350,000.
- Volker brings medtech experience from Abbott, CSI, St. Jude Medical; holds Wharton MBA and CFA.
- McClurg entered Transition and Release Agreement dated April 28, 2026; will receive salary/benefits through retirement and provide general release.
- McClurg's equity awards (options/RSUs) continue per plan terms; no immediate change to equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/0001213900-26-049748-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390026049748/ea0288229-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-049748

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer